MLTX
MoonLake Immunotherapeutics Class AstockNASDAQ
Market OpenNov 19, 2026 2:59:12 PM EST
11.03USD+2.271%(+0.24)820,457
Pre-marketNov 19, 2026 9:28:30 AM EST
10.75USD-0.371%(-0.04)
Loading…
Loading…
937.88M
Healthcare
Biotechnology
HQ
Zug, Switzerland
Previous Close
$10.79
Beta
1.64
52-Week High
$23.29 2026-06-22
52-Week Low
$9.46 2026-10-16
SMA 50
$11.68
SMA 200
$16.19
Avg. Vol 10D
1.35M
Avg. Vol 30D
1.68M
Avg. Vol 90D
1.52M
Relative Vol
0.49
85.11M
75.12M
88.26%
5,473,842
7.29%
2.85
60%/40%
49.73%
42.00%
0.3000%
1,300,000
45
168
-273.5M
-3.66
-244.0M
-81.57
Nov 11, 2026
Nov 4, 2026
MoonLake Immunotherapeutics GAAP EPS of -$0.93 misses by $0.15 ·
Seeking Alpha
MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update ·
GlobeNewswire Inc.
Oct 18, 2026
Sep 30, 2026
MoonLake Immunotherapeutics submits sonelokimab BLA ·
Seeking Alpha
MLTX Profile
moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
MLTX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 12.87 | 2026-11-12 | -14.38% | 1.638 |
| 1M | 9.75 | 2026-10-19 | +13.03% | 2.104 |
| 3M | 16.74 | 2026-08-19 | -34.17% | 1.864 |
| 6M | 16.37 | 2026-05-19 | -32.68% | 1.419 |
| 1Y | 13.54 | 2025-11-19 | -18.61% | 1.643 |
| 2Y | 49.33 | 2024-11-19 | -77.66% | — |
| 5Y | 12.88 | 2022-04-07 | -14.44% | 0.716 |
MLTX Stock Summary
MoonLake Immunotherapeutics Class A (NASDAQ:MLTX) stock price today is $11.02, and today's volume is 816,660. MLTX is up 2.132% today. The 30 day average volume is 1.68M. MLTX market cap is $937.88M with 85.11M shares outstanding.